Supernus Pharmaceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Supernus Pharmaceuticals, Inc. (SUPN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income73.871.3260.7153.42126.95113.06110.99
Depreciation & Amortization80.4184.8685.5450.1018.1422.367.06
Deferred Income Tax-20.14-25.71-26.32-4.990.57-5.83-4.17
Stock Based Compensation27.7626.7617.5717.9116.560.000.00
Change in Working Capital-2.05-9.14-24.247.47-36.523.10-4.73
Change in Accounts Receivable2.0818.77-16.373.87-34.610.000.00
Change in Inventory15.816.11-17.86-14.58-10.120.000.00
Change in Accounts Payable-15.02-36.29-19.1618.188.270.000.00
Change in Other Working Capital-4.924.9129.14-3.90-0.060.000.00
Other Operating Activities12.114.91-15.2027.593.9214.7710.21
Net Cash from Operating Activities171.95111.09116.83127.13138.40143.13128.99
Investing Activities
Capital Expenditures-0.73-0.55-0.41-2.05-3.692.74-0.84
Acquisitions0.00-1.52-0.51-318.22-298.540.000.00
Purchases of Investments-688.01-101.62-216.25231.82267.530.000.00
Sales/Maturities of Investments498.86370.90190.74229.78263.84-155.19-411.83
Other Investing Activities0.01-0.55-0.4110.84-18.691.35-0.81
Net Cash from Investing Activities-189.87268.73-216.66-81.91-34.70-157.92-413.48
Financing Activities
Debt Repayment0.00-495.500.00-138.32-0.800.00-92.90
Common Stock Issued14.916.6112.427.104.363.9311.58
Common Stock Repurchased0.00-1.990.000.000.000.000.00
Other Financing Activities-2.72-1.99-22.900.80-0.800.00-10.44
Net Cash from Financing Activities12.19-397.88-10.48-130.423.563.93376.44
Summary
Net Change in Cash-5.72-18.07-110.31-85.21107.26-10.8791.94
Cash at Beginning of Period75.0593.12203.43288.64181.38192.25100.30
Cash at End of Period69.3375.0593.12203.43288.64181.38192.25
Free Cash Flow171.23110.53116.41127.13134.71140.39128.14
Supplemental Disclosures
Interest Paid0.001.952.522.522.522.521.34
Income Taxes Paid53.2536.6016.2025.1945.4351.5434.77